Back to search

FK506 and cyclosporin A inhibit growth factor-stimulated human keratinocyte proliferation by blocking cells in the G0G1 phases of the cell cycle

Data up to Jan 2025

Published1996
Citations33
References39

Total Citations Per Year

Abstract

References (39)

FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro.

1987 • 1,209 citations

Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes.

1989 • 844 citations

Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA) structural conservation and the detection of a nucleolar form

1990 • 736 citations

Cell migration is essential for sustained growth of keratinocyte colonies: The roles of transforming growth factor-α and epidermal growth factor

1987 • 703 citations

TGF-β1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains

1990 • 612 citations

Reversible inhibition of normal human prokeratinocyte proliferation by type beta transforming growth factor-growth inhibitor in serum-free medium.

1986 • 559 citations

Overexpression of Transforming Growth Factor α in Psoriatic Epidermis

1989 • 537 citations

Cyclosporine Improves Psoriasis in a Double-blind Study

1986 • 535 citations

Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal inflamed skin: Modulation by recombinant gamma interferon and tumor necrosis factor

1989 • 505 citations

Transgenic mice provide new insights into the role of TGF-alpha during epidermal development and differentiation.

1991 • 407 citations

Changes in Keratinocyte Maturation During Wound Healing

1987 • 375 citations

Altered [125I] Epidermal Growth Factor Binding and Receptor Distribution in Psoriasis

1986 • 289 citations

Clearance of psoriasis with low dose cyclosporin.

1986 • 233 citations

Detection of transforming growth factor alpha in normal, malignant, and hyperproliferative human keratinocytes.

1988 • 227 citations

Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques.

1986 • 196 citations

Upper Keratinocytes of Psoriatic Skin Lesions Express High Levels of NAP-1/IL-8 mRNA In Situ

1991 • 175 citations

Epidermal Keratiocytes Express the Adhesion Molecule Intercellular Adhesion Molecule-1 in Inflammatory Dermatoses.

1989 • 170 citations

Tacrolimus (FK 506)—A New Therapeutic Agent for Severe Recalcitrant Psoriasis

1992 • 161 citations

Cytokines in skin lesions of psoriasis

1990 • 140 citations

Increased expression of epidermal IL-8 receptor in psoriasis. Down-regulation by FK-506 in vitro.

1993 • 123 citations

Control of growth and differentiation in vitro of human keratinocytes cultured in serum-free medium

1987 • 119 citations

Levels of Cyclosporin in Epidermis of Treated Psoriasis Patients Differentially Inhibit Growth of Keratinocytes Cultured in Serum Free Versus Serum Containing Media

1988 • 116 citations

Cyclosporine improves psoriasis in a double-blind study

1986 • 112 citations

The Effect of Cyclosporin A on Epidermal Cells. II. Cyclosporin A Inhibits Proliferation of Normal and Transformed Keratinocytes

1988 • 100 citations

Differential effects of epidermal growth factor, transforming growth factor, and insulin on DNA and protein synthesis and morphology in serum-free cultures of AKR-2B cells.

1984 • 93 citations

Interleukin 6 and expression of its receptor on epidermal keratinocytes

1990 • 82 citations

HLA-DR antigen expression on keratinocytes in highly inflamed parts of psoriatic lesions

1987 • 64 citations

Additive and synergistic antiproliferative effects of cyclosporin A and gamma interferon on cultured human keratinocytes.

1988 • 60 citations

Human keratinocyte culture. Identification and staging of epidermal cell subpopulations.

1986 • 56 citations

Cyclosporin A inhibits keratinocyte cytokine gene expression

1994 • 52 citations

Differential Inhibition of Cutaneous T-Cell-Mediated Reactions and Epidermal Cell Proliferation by Cyclosporin A, FK-506, and Rapamycin

1994 • 51 citations

Cyclosporin a inhibits directly in vivo keratinocyte proliferation of living human skin

1989 • 48 citations

Cyclosporine in psoriasis treatment. Inhibition of keratinocyte cell-cycle progression in G1 independent of effects on transforming growth factor alpha/epidermal growth factor receptor pathways

1991 • 45 citations

Cyclosporin A Inhibits Directly In Vivo Keratinocyte Proliferation of Living Human Skin.

1989 • 30 citations

DNA Flow Cytometry on Human Epidermis: I. Methodological Studies on Normal Skin

1980 • 30 citations

Tacrolimus (FK 506)--a new therapeutic agent for severe recalcitrant psoriasis

1992 • 28 citations

Cannulation of difficult oesophageal strictures with angiographic catheters

1986 • 22 citations

Interleukin-1 Does Not Stimulate DNA Synthesis of Cultured Human Keratinocytes Growth-Arrested in Growth-Factor-Depleted Medium

1990 • 16 citations

Neither cyclosporin A nor FK506 affects adenylate cyclase responses of fetal rat keratinizing epidermal cells (FRSK cells) at concentrations that inhibit thymidine incorporation

1993 • 2 citations

Cited By (0)

Loading...
FK506 and cyclosporin A inhibit growth factor-stimulated human keratinocyte proliferation… (1996) – Journal of Dermatological Science | Metascience Observatory Explorer